Dr. Lili Yang - collaborative research leads to the development of novel technology that positions ‘off-the-shelf’ Cancer Immunotherapy for the Clinic.
Dr. Tim O’Sullivan – led an interdisciplinary research team that discovered a previously unknown NK cell immunodeficiency associated with the neurological syndrome MEF2C haploinsufficiency syndrome.
Dr. Kent Hill – our group’s discovery of Social Motility as an emergent behavior in African trypanosomes demonstrated that these single-celled parasites are capable of coordinating their activities as a group.
Dr. Yvonne Chen – developed a CD19/CD20 bispecific chimeric antigen receptor (CAR)-T cell therapy that was subsequently evaluated in the first investigator-initiated CAR-T cell therapy trial at UCLA.
